This white paper is the second edition in a series following the publication of Edition 1 in July 2019. In January 2020 Eagle Alpha hosted its largest ever conference in New York with 800 attendees across buyside, private equity, corporates and data vendors. The corporate breakout session explored corporate use cases for external data. Within this paper we build on these discussions and present relevant use cases and key insights for corporates looking to become more data- driven in their decision-making. The paper will:
-      - Introduce alternative data.
-      - Outline the benefit for alternative data for timely insights.
-      - Detail 11 case studies across various alternative data types relevant to tracking COVID-19.
-      - Outline Eagle Alpha’s solutions for tracking impact and recovery of the coronavirus outbreak.
Coronavirus White Paper
This report is the first in a series of reports published in March 2020 by Eagle Alpha on the use of alternative data to track the impact of the Coronavirus. The purpose of this report is to provide buyside funds, private equity firms, corporates, governments and central banks with examples of how alternative data can be leveraged for timely insights.
Coronavirus Data Package
With the recent coronavirus outbreak, it has become more evident than ever that traditional research and data sources don’t provide investors with timely or adequate insights. Alternative data is the only way investors can obtain timely and granular insights.
Private Equity White Paper
There are currently over 1,150 alternative datasets in the Eagle Alpha database. Eagle Alpha has identified hundreds specifically relevant to private equity firms. We are uniquely positioned to form partnerships with innovative private equity firms to profit from alternative data.